Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Elife ; 102021 02 02.
Artigo em Inglês | MEDLINE | ID: mdl-33526168

RESUMO

A farnesylated and methylated form of prelamin A called progerin causes Hutchinson-Gilford progeria syndrome (HGPS). Inhibiting progerin methylation by inactivating the isoprenylcysteine carboxylmethyltransferase (ICMT) gene stimulates proliferation of HGPS cells and improves survival of Zmpste24-deficient mice. However, we don't know whether Icmt inactivation improves phenotypes in an authentic HGPS mouse model. Moreover, it is unknown whether pharmacologic targeting of ICMT would be tolerated by cells and produce similar cellular effects as genetic inactivation. Here, we show that knockout of Icmt improves survival of HGPS mice and restores vascular smooth muscle cell numbers in the aorta. We also synthesized a potent ICMT inhibitor called C75 and found that it delays senescence and stimulates proliferation of late-passage HGPS cells and Zmpste24-deficient mouse fibroblasts. Importantly, C75 did not influence proliferation of wild-type human cells or Zmpste24-deficient mouse cells lacking Icmt, indicating drug specificity. These results raise hopes that ICMT inhibitors could be useful for treating children with HGPS.


Assuntos
Senescência Celular/efeitos dos fármacos , Progéria/tratamento farmacológico , Proteínas Metiltransferases/efeitos dos fármacos , Piranos/farmacologia , Animais , Aorta/patologia , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Modelos Animais de Doenças , Humanos , Lamina Tipo A/metabolismo , Camundongos , Camundongos Knockout , Miócitos de Músculo Liso , Progéria/genética , Progéria/patologia , Proteínas Metiltransferases/genética , Proteínas Metiltransferases/metabolismo
2.
Am J Physiol Cell Physiol ; 279(2): C429-39, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10913010

RESUMO

Aldosterone increases Na(+) reabsorption by renal epithelial cells: the acute actions (<4 h) appear to be promoted by protein methylation. This paper describes the relationship between protein methylation and aldosterone's action and describes aldosterone-mediated targets for methylation in cultured renal cells (A6). Aldosterone increases protein methylation from 7.90 +/- 0.60 to 20.1 +/- 0.80 methyl ester cpm/microg protein. Aldosterone stimulates protein methylation by increasing methyltransferase activity from 14.0 +/- 0.64 in aldosterone-depleted cells to 31.8 +/- 2.60 methyl ester cpm/microg protein per hour in aldosterone-treated cells. Three known methyltransferase inhibitors reduce the aldosterone-induced increase in methyltransferase activity. One of these inhibitors, the isoprenyl-cysteine methyltransferase-specific inhibitor, S-trans, trans-farnesylthiosalicylic acid, completely blocks aldosterone-induced protein methylation and also aldosterone-induced short-circuit current. Aldosterone induces protein methylation in two molecular weight ranges: near 90 kDa and around 20 kDa. The lower molecular weight range is the weight of small G proteins, and aldosterone does increase both Ras protein 1.6-fold and Ras methylation almost 12-fold. Also, Ras antisense oligonucleotides reduce the activity of Na(+) channels by about fivefold. We conclude that 1) protein methylation is essential for aldosterone-induced increases in Na(+) transport; 2) one target for methylation is p21(ras); and 3) inhibition of Ras expression or Ras methylation inhibits Na(+) channel activity.


Assuntos
Aldosterona/farmacologia , Células Epiteliais/efeitos dos fármacos , Proteínas Metiltransferases/efeitos dos fármacos , Canais de Sódio/efeitos dos fármacos , Proteínas ras/efeitos dos fármacos , Animais , Células Cultivadas , Células Epiteliais/metabolismo , Túbulos Renais/efeitos dos fármacos , Túbulos Renais/metabolismo , Metilação , Proteínas Metiltransferases/metabolismo , Canais de Sódio/metabolismo , Proteínas ras/metabolismo
3.
Artigo em Inglês | MEDLINE | ID: mdl-10665370

RESUMO

Urea is a protein unfolding agent that can accumulate to locally high concentrations in tissues of many organisms. We used Drosophila melanogaster to test the hypothesis that urea loading would promote formation of isoaspartate (beta-carboxyl-linked aspartate), a common form of protein damage that occurs most readily in unstructured polypeptides and flexible regions of folded proteins. Ten populations of flies were tested; five control populations of urea-sensitive flies and five previously selected urea-tolerant populations. We measured the effects of urea consumption on levels of both isoaspartate and protein L-isoaspartate methyltransferase (PIMT), an enzyme believed to function in the repair or removal of isoaspartyl proteins. For both sets of populations, urea feeding for 6 days increased isoaspartyl levels by approximately 60%, supporting the idea that disruption of protein secondary and tertiary structures can accelerate the formation of isoaspartate in vivo. Urea feeding tended to increase PIMT activity in both control and urea-tolerant populations. There were no significant differences in PIMT activities or isoaspartyl levels between the control and urea-tolerant flies raised on normal or urea food. The latter findings indicate that urea tolerance evolved in the selected populations without any significant change in PIMT expression or activity.


Assuntos
Ácido Aspártico/metabolismo , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/metabolismo , Proteínas de Insetos/metabolismo , Proteínas Metiltransferases/metabolismo , Ureia/farmacologia , Animais , Ácido Aspártico/efeitos dos fármacos , Proteínas de Insetos/efeitos dos fármacos , Isomerismo , Larva/efeitos dos fármacos , Larva/metabolismo , Proteína D-Aspartato-L-Isoaspartato Metiltransferase , Proteínas Metiltransferases/efeitos dos fármacos , Seleção Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA